SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002933
Filing Date
2008-03-17
Accepted
2008-03-17 16:12:25
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183818z10-k.htm 10-K 951051
2 EXHIBIT 10.42 a2183818zex-10_42.htm EX-10.42 15383
3 EXHIBIT 10.43 a2183818zex-10_43.htm EX-10.43 10952
4 EXHIBIT 23.1.1 a2183818zex-23_11.htm EX-23.1.1 3184
5 EXHIBIT 31.1.1 a2183818zex-31_11.htm EX-31.1.1 7081
6 EXHIBIT 31.2.1 a2183818zex-31_21.htm EX-31.2.1 7095
7 EXHIBIT 32.1.1 a2183818zex-32_11.htm EX-32.1.1 4372
8 G687230.JPG g687230.jpg GRAPHIC 30962
9 G424152.JPG g424152.jpg GRAPHIC 7461
10 G1027083.JPG g1027083.jpg GRAPHIC 6198
  Complete submission text file 0001047469-08-002933.txt   1062441
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32966 | Film No.: 08693112
SIC: 2836 Biological Products, (No Diagnostic Substances)